University of Patras
Συγκριτική μελέτη των τοξικών επιδράσεων της κανναβιδιόλης και της νικοτίνης σε πνευμονικά και ενδοθηλιακά κύτταρα και διερεύνηση της αγχολυτικής και αντιοξειδωτικής δράσης της κανναβιδιόλης in vivo
Abstract
dc:descriptionSmoking is a major risk factor for numerous diseases, including cardiovascular, respiratory, and neurodegenerative disorders. Nicotine, the primary active compound in tobacco, is involved in biological mechanisms related to oxidative stress, inflammation, cellular dysfunction, and dysregulation of the nervous and cardiovascular systems. At acutely high doses or with prolonged use, nicotine may exacerbate anxiety-like behavior by impairing brain plasticity through the downregulation of Brain-Derived Neurotrophic Factor (BDNF) and disruption of cholinergic neurotransmission. The rapid expansion of Reduced Risk Products (RRPs), such as electronic cigarettes, heated tobacco products (e.g., IQOS, Glo), and cannabidiol (CBD)-containing refill liquids, necessitates independent scientific evaluation of their toxicity and biological effects at both the cellular and systemic levels. This thesis comparatively investigates and in vivo experimental approaches. In the in vitro part, the effects of tobacco smoke, heated tobacco products, e-cigarette aerosols, and CBD-liquids were assessed on pulmonary and endothelial cell lines. Parameters examined included cell viability, secretion of pro-inflammatory cytokines (MMP-1, IL-6, IL-8), wound healing capacity (scratch assay), and monocyte (MM6) adhesion to HCAEC cells. RRPs exhibited lower cytotoxicity compared to conventional cigarette smoke, with CBD-liquids demonstrating the most favorable profile regarding cell survival and inflammatory response. In the in vivo part, a well-established mouse model (C57BL/6) was used, with high-dose nicotine administration to induce anxiety-like behavior. Co-administration of CBD resulted in a significant reduction in anxiety markers (open field test), preservation of BDNF levels in the cerebral hemispheres, modulation of oxidative stress markers (GSH, MDA), and decreased production of pro-inflammatory cytokines (TNF-α, IL-6). Furthermore, metabolic homeostasis was maintained, and cholinergic function was favorably regulated (acetylcholine levels and acetylcholinesterase activity). The findings of this study support the potential neuroprotective and anxiolytic effects of CBD against nicotine-induced toxicity, highlighting its therapeutic potential.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mesiakaris, Konstantinos
- Μεσιακάρης, Κωνσταντίνος
Subjects
dc:subject × 33- Νικοτίνη
- Κανναβιδιόλη
- Οξειδωτικό στρες
- Εγκεφαλικός νευροτροφικός παράγοντας
- Ηλεκτρονικά τσιγάρα
- Προϊόντα θερμαινόμενου καπνού
- Αγχολυτική δράση
- Ακετυλοχολίνη
- AChE-ακετυλ-χοληνεστεράση
- Νευροπροστασία
- Προφλεγμονώδεις κυτταροκίνες
- Nicotine
- Cannabidiol
- Brain oxidative stress
- Anxiety
- Brain-derived neurotrophic factor
- Electronic cigarettes
- Heated tobacco products
- Inflammation
- Anxiolytic activity
- Acetylcholinesterase (AChE)
- Acetylcholine
- Neuroprotection
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, γενικά
- Βασική Ιατρική
- Φαρμακολογία και Φαρμακευτική
- Health Sciences
- Medical and Health Sciences
- Health sciences, general
- Basic Medicine
- Pharmacology and Pharmacy
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59395